311 related articles for article (PubMed ID: 18357404)
1. Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin.
Abdul-Ghani MA; Molina-Carrion M; Jani R; Jenkinson C; Defronzo RA
Acta Diabetol; 2008 Sep; 45(3):147-50. PubMed ID: 18357404
[TBL] [Abstract][Full Text] [Related]
2. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
3. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
4. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.
Moors CC; van der Zijl NJ; Diamant M; Blaak EE; Goossens GH
Int J Obes (Lond); 2012 May; 36(5):709-17. PubMed ID: 21712806
[TBL] [Abstract][Full Text] [Related]
5. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
[TBL] [Abstract][Full Text] [Related]
6. Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose.
Hong J; Gui MH; Gu WQ; Zhang YF; Xu M; Chi ZN; Zhang Y; Li XY; Wang WQ; Ning G
Diabet Med; 2008 Jan; 25(1):73-9. PubMed ID: 18199133
[TBL] [Abstract][Full Text] [Related]
7. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study.
Gastaldelli A; Gaggini M; DeFronzo RA
Diabetes; 2017 Apr; 66(4):815-822. PubMed ID: 28052966
[TBL] [Abstract][Full Text] [Related]
8. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
[TBL] [Abstract][Full Text] [Related]
10. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.
Abdul-Ghani MA; Jenkinson CP; Richardson DK; Tripathy D; DeFronzo RA
Diabetes; 2006 May; 55(5):1430-5. PubMed ID: 16644701
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
Weyer C; Bogardus C; Pratley RE
Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
[TBL] [Abstract][Full Text] [Related]
13. Glucose Tolerance in Non-Diabetic Adult Subjects of an Urban West-African Population.
Awede B; Lawani S; Adehan G; Akakpo J; Dossou E; Amoussou-Guenou M; Djrolo F
Niger J Physiol Sci; 2017 Dec; 32(2):159-164. PubMed ID: 29485636
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.
Tripathy D; Carlsson M; Almgren P; Isomaa B; Taskinen MR; Tuomi T; Groop LC
Diabetes; 2000 Jun; 49(6):975-80. PubMed ID: 10866050
[TBL] [Abstract][Full Text] [Related]
15. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute changes in fasting glucose and free fatty acid concentrations on indices of β-cell function and glucose metabolism in subjects without diabetes.
Schembri Wismayer D; Laurenti MC; Song Y; Egan AM; Welch AA; Bailey KR; Cobelli C; Dalla Man C; Jensen MD; Vella A
Am J Physiol Endocrinol Metab; 2023 Aug; 325(2):E119-E131. PubMed ID: 37285600
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
Stefan N; Stumvoll M; Bogardus C; Tataranni PA
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
[TBL] [Abstract][Full Text] [Related]
18. Isolated impaired fasting glucose and peripheral insulin sensitivity: not a simple relationship.
Kim SH; Reaven GM
Diabetes Care; 2008 Feb; 31(2):347-52. PubMed ID: 18000184
[TBL] [Abstract][Full Text] [Related]
19. Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose.
Goossens GH; Moors CC; Jocken JW; van der Zijl NJ; Jans A; Konings E; Diamant M; Blaak EE
Nutrients; 2016 Mar; 8(3):164. PubMed ID: 26985905
[TBL] [Abstract][Full Text] [Related]
20. Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics.
Fiorentino TV; Pedace E; Succurro E; Andreozzi F; Perticone M; Sciacqua A; Perticone F; Sesti G
J Clin Endocrinol Metab; 2019 Jul; 104(7):2911-2924. PubMed ID: 30848793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
